Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 12
Nuvo Pharma Acquires Ex-US Rights to Resultz from Piedmont Pharma for USD7 Million 14
Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 15
Partnerships 16
Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 16
Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 17
Licensing Agreements 18
Gebro Pharma Enters into Licensing Agreement with Nuvo Pharma 18
Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 19
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 20
Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 21
Equity Offering 22
Nuvo Research Completes Private Placement Of Units For US$2.8 Million 22
Asset Transactions 23
Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 23
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 25
Tioga Acquires HTE Formulation Patents from Nuvo Research 26
Nuvo Pharmaceuticals Inc – Key Competitors 27
Nuvo Pharmaceuticals Inc – Key Employees 28
Nuvo Pharmaceuticals Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Aug 02, 2018: Nuvo Pharmaceuticals announces 2018 second quarter results 30
May 10, 2018: Nuvo Pharmaceuticals Announces 2018 First Quarter Results 32
Mar 23, 2018: Nuvo Pharmaceuticals Announces 2017 Fourth Quarter and Year-End Results 34
Nov 01, 2017: Nuvo Pharmaceuticals Announces 2017 Third Quarter Results 36
Aug 09, 2017: Nuvo Pharmaceuticals Announces 2017 Second Quarter Results 39
May 10, 2017: Nuvo Pharmaceuticals Announces 2017 First Quarter Results 42
Mar 01, 2017: Nuvo Pharmaceuticals Announces 2016 Year-End and Fourth Quarter Results 44
Corporate Communications 47
Nov 22, 2017: Nuvo Pharmaceuticals Announces Appointment of Jesse Ledger as President & Chief Executive Officer 47
Legal and Regulatory 48
Aug 20, 2018: Nuvo Pharmaceuticals announces extension of exclusivity period with Aralez and Deerfield 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Nuvo Pharma to Acquire Pharma Business from Aralez Pharma for USD110 Million 12
Nuvo Pharma Acquires Ex-US Rights to Resultz from Piedmont Pharma for USD7 Million 14
Nuvo Research Reacquires Pennsaid Rights from Paladin Labs 15
Nuvo Research Enters Into Co-Development Agreement With Ferndale Labs And Contract Research Organization 16
Nuvo Research Enters Into Distribution Agreement With NovaMedica For Pennsaid 17
Gebro Pharma Enters into Licensing Agreement with Nuvo Pharma 18
Sayre Therapeutics Enters into Licensing Agreement with Nuvo Pharma 19
Nuvo Research Enters into Licensing Agreement with Galderma Pharma for Pliaglis 20
Nuvo Research Enters Into Licensing Agreement With Paladin Labs For Synera 21
Nuvo Research Completes Private Placement Of Units For US$2.8 Million 22
Horizon Pharma Acquires US Rights to Pennsaid 2% from Nuvo Research for USD45 Million 23
Galen Acquires US Rights For Synera From Nuvo Research For USD14.5 Million 25
Tioga Acquires HTE Formulation Patents from Nuvo Research 26
Nuvo Pharmaceuticals Inc, Key Competitors 27
Nuvo Pharmaceuticals Inc, Key Employees 28
Nuvo Pharmaceuticals Inc, Subsidiaries 29
List of Figures
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvo Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvo Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer